Use of affinity‐directed liquid chromatography‐mass spectrometry to map the epitopes of a factor VIII inhibitor antibody fraction

Ananyeva, 2009, Inhibitors in Hemophilia A: advances in elucidation of inhibitory mechanism and in inhibitor management with bypassing activity, Semin Thromb Hemost, 25, 735, 10.1055/s-0029-1245106 Lollar, 2004, Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX, J Thromb Haemost, 2, 1082, 10.1111/j.1538-7836.2004.00802.x Fay, 2004, Activation of factor VIII and mechanisms of cofactor action, Blood Rev, 18, 1, 10.1016/S0268-960X(03)00025-0 Vehar, 1984, Structure of human factor VIII, Nature, 312, 337, 10.1038/312337a0 Scandella, 1989, Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization, Blood, 74, 1618, 10.1182/blood.V74.5.1618.1618 Scandella, 1988, Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli, Proc Natl Acad Sci USA, 85, 6152, 10.1073/pnas.85.16.6152 Villard, 2003, Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti‐factor VIII inhibitor, Blood, 102, 949, 10.1182/blood-2002-06-1886 Kopecky, 2006, Mapping of FVIII inhibitor epitopes using cellulose‐bound synthetic peptide arrays, J Immunol Methods, 308, 90, 10.1016/j.jim.2005.10.016 Healey, 1995, Residues 484‐508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII, J Biol Chem, 270, 14505, 10.1074/jbc.270.24.14505 Healey, 1988, Residues Glu2181‐Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII, Blood, 92, 3701, 10.1182/blood.V92.10.3701 Barrow, 2000, Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply‐substituted hybrid human/porcine factor VIII molecules, Blood, 95, 564, 10.1182/blood.V95.2.564 Ansong, 2006, Epitope mapping factor VIII A2 domain by affinity‐directed mass spectrometry: residues 497‐510 and 584‐593 comprise a discontinuous epitope for the monoclonal antibody R8B12, J Thromb Haemost, 4, 842, 10.1111/j.1538-7836.2006.01831.x Nogami, 2003, Altered interactions between the A1 and A2 subunits of factor VIIIa following cleavage of A1 subunit by factor Xa, J Biol Chem, 278, 1634, 10.1074/jbc.M209811200 Perkins, 1999, Probability‐based protein identification by searching sequence databases using mass spectrometry data, Electrophoresis, 20, 3351, 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2 Scandella, 2001, In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic, Thromb Res, 101, 377, 10.1016/S0049-3848(00)00418-7 Lollar, 1994, Inhibition of human factor VIIIa by anti‐A2 subunit antibodies, J Clin Invest, 93, 2497, 10.1172/JCI117259 Fay, 1999, Human inhibitor antibodies specific for the factor VIII A2 domain disrupt the interaction between the subunit and factor IXa, J Biol Chem, 274, 29826, 10.1074/jbc.274.42.29826 Fay, 1994, Factor VIIIa A2 subunit residues 558–565 represent a factor IXa interactive site, J Biol Chem, 269, 20522, 10.1016/S0021-9258(17)32024-0 Scandella, 1995, Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid‐binding site, Blood, 86, 1811, 10.1182/blood.V86.5.1811.bloodjournal8651811 Pratt, 1999, Structure of the C2 domain of human factor VIII at 1.5 A resolution, Nature, 402, 439, 10.1038/46601 Foster, 1988, J Clin Invest, 82, 123, 10.1172/JCI113559 Raut, 2003, Anti‐heavy‐chain monoclonal antibodies directed to the acidic regions of the factor VIII molecule inhibit the binding of factor VIII to phospholipids and von Willebrand factor, Thromb Haemost, 90, 385, 10.1160/TH02-09-0086 Lapan, 1997, Localization of a factor X interactive site in the A1 subunit of factor VIIIa, J Biol Chem, 272, 2082, 10.1074/jbc.272.4.2082 Kemball‐Cook, 1998, The factor VIII structure and mutation resource site: HAMSTeRS version 4, Nucleic Acids Res, 26, 216, 10.1093/nar/26.1.216 Ngo, 2008, Crystal structure of human factor VIII: implications for the formation of the factor IXa‐factor VIIIa complex, Structure, 16, 597, 10.1016/j.str.2008.03.001